SCHEDULE 13G/A 0001193125-22-041136 0001647900 XXXXXXXX LIVE 4 Common Stock, par value $0.0001 per share 03/31/2025 0001672688 Absci Corporation 00091E109 18105 SE Mill Plain Blvd Vancouver WA 98683 Rule 13d-1(d) Phoenix Venture Partners II, LP DE 4745115.00 0.00 4745115.00 0.00 4745115.00 N 3.7 PN Phoenix General Partner II LLC DE 4745115.00 0.00 4745115.00 0.00 4745115.00 N 3.7 OO Shares reported in this table are held by Phoenix Venture Partners II, LP, of which the Reporting Person is the sole general partner. Absci Corporation 18105 SE Mill Plain Blvd Vancouver, WA, 98683 This joint statement on Schedule 13G is being filed by Phoenix General Partner II LLC, a Delaware limited liability company (the "General Partner"), and Phoenix Venture Partners II, LP, a Delaware limited partnership (the "Fund" and, together with the General Partner, the "Reporting Persons"). The business address of each of the Reporting Persons is 1700 El Camino Real, Suite 355, San Mateo, CA 94402. The Fund is a Delaware limited partnership; and the General Partner is a Delaware limited liability company. Y 4,745,115 shares of common stock, par value $0.0001 per share (the "Common Stock"). The amounts and percentages of beneficial ownership reported herein are as of March 31, 2025. 3.7%. The percentages of beneficial ownership reported herein, and on each Reporting Person's cover page to this Schedule 13G, are based on a total of 127,333,887 shares of Common Stock issued and outstanding as of February 28, 2025, as reported in the quarterly report of the Issuer on Form 10-K for its fiscal year ended December 31, 2024. 4,745,115 shares of Common Stock 0 4,745,115 shares of Common Stock 0 N Y Y Y Y Y Y Phoenix Venture Partners II, LP /s/ John Chen 05/15/2025 Phoenix General Partner II LLC /s/ John Chen 05/15/2025